Unconfigured Ad

Collapse
X
 
  • Time
  • Show
Clear All
new posts

  • robs
    replied
    Originally posted by marcowanger View Post
    Important things to do now

    1> Please suggest success cases of using SEQanswers (see http://seqanswers.com/wiki/Publicati...for_SEQanswers for current suggested case studies)

    2> Rearrange the figures (see gdoc)
    1> I tried to put the use cases in text form from the current list. I rearranged them so they are grouped together. Feel free to convert back to the list if you don't like it. We need to add some more examples of how the discussions lead to publications (at least one example, if we have).

    2> done

    Leave a comment:


  • marcowanger
    replied
    Hi all,

    I think the MS is almost ready now !!!!

    We have written a lot today.

    Leave a comment:


  • marcowanger
    replied
    Important things to do now

    1> Please suggest success cases of using SEQanswers (see http://seqanswers.com/wiki/Publicati...for_SEQanswers for current suggested case studies)

    2> Rearrange the figures (see gdoc)

    Leave a comment:


  • marcowanger
    replied
    Anyone want to nominate usage success cases of SEQanswers?

    Leave a comment:


  • marcowanger
    replied
    Given the current progress, we can finalize the MS within this week.

    Good work everyone!

    Leave a comment:


  • marcowanger
    replied
    In fact, some while ago people suggested to merge the content of BioStar and Seqanswers into one places or sync content across two places ......

    Leave a comment:


  • robs
    replied
    Originally posted by genericforms View Post
    Your figure revisions look great. As far as I am concerned, these figures are ready for submission.
    Thanks to your suggestions. It's all a result of joined ideas.

    I edited the first two sections and think they look pretty good. We should now concentrate on the last three sections. Almost there.

    Leave a comment:


  • adaptivegenome
    replied
    Your figure revisions look great. As far as I am concerned, these figures are ready for submission.

    Leave a comment:


  • robs
    replied
    Originally posted by marcowanger View Post
    when did ECO said this? I couldn't find the exact post...
    Discussion of next-gen sequencing related bioinformatics: resources, algorithms, open source efforts, etc

    Leave a comment:


  • marcowanger
    replied
    (off-topic), robs, please check email, added you in Linkedin

    Originally posted by robs View Post
    This might be something we could try to address in the Outlook section.

    Leave a comment:


  • marcowanger
    replied
    Originally posted by genericforms View Post
    This is ideal. Just put the PUBMED ID in parenthesis. I will go back and swap with endnote citations.
    Thanks genericforms. In the introduction, there are considerable number of citation from blog (Well, no journal will condem the traditional pillar of scientific publishing...anyway). So probably no easy import and export from endnote, please manually create the reference in endnote (is troublesome I know). I can help if needed, genericforms. I am used to Endnote.

    I want to stress, the sources which I quote are reputable as I can tell.

    I will continue writing the success cases tomorrow.

    Leave a comment:


  • adaptivegenome
    replied
    Originally posted by marcowanger View Post
    re-writed the introduction part. I hope you will find the argument make sense..

    Language is rough, but the idea is there
    Looks good!

    Leave a comment:


  • adaptivegenome
    replied
    Originally posted by marcowanger View Post
    references are added in text for now.
    This is ideal. Just put the PUBMED ID in parenthesis. I will go back and swap with endnote citations.

    Leave a comment:


  • marcowanger
    replied
    i added examples and comments from Keith's and others' blog and note the debate on recently hot debate on RNA-editing. Interesting, someone continue to cite Li's article without notice the counter-argument proposed in another paper....

    Leave a comment:


  • marcowanger
    replied
    re-writed the introduction part. I hope you will find the argument make sense..

    Language is rough, but the idea is there

    Leave a comment:

Latest Articles

Collapse

  • SEQadmin2
    16S/ITS Profiling vs. Shotgun Metagenomics: What Changes in Your Workflow?
    by SEQadmin2




    NGS has revolutionized clinical microbiology by offering new ways to identify and surveil pathogens without prior knowledge of the target. One popular approach is 16S rRNA and ITS amplicon sequencing, which targets specific microbial markers. But studies are increasingly incorporating shotgun metagenomics, a technique that sequences all DNA from a sample without targeting specific microbial markers. This approach allows more detailed taxonomic classification, detection...
    Today, 06:46 AM
  • SEQadmin2
    Multiomic Liquid Biopsy: What DNA/RNA Panels Reveal That DNA Alone Can’t
    by SEQadmin2



    Tumors contain complex mixtures of cell populations that evolve in response to treatment and host-specific factors. Tissue biopsies provide only static snapshots of a tumor’s state. But what if we could follow that evolution over time using a minimally invasive technique?

    Liquid biopsies can detect tumor-derived material circulating in the bloodstream, providing a way to study treatment response, detect emerging resistance, and discover new biomarkers. Circulating
    ...
    10-14-2026, 09:55 AM

ad_right_rmr

Collapse

News

Collapse

Topics Statistics Last Post
Started by SEQadmin2, 10-28-2026, 09:57 AM
0 responses
22 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 10-28-2026, 09:51 AM
0 responses
14 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 10-22-2026, 11:13 AM
0 responses
68 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 10-22-2026, 10:48 AM
0 responses
48 views
0 reactions
Last Post SEQadmin2  
Working...